The first volunteer due for injection with Israel’s coronavirus vaccine says he is feeling optimistic, and described his participation in the trial as “a historic opportunity.”
Clinical trials for the Brilife vaccine, developed by the Israel Institute for Biological Research, start Sunday at Sheba Medical Center in Ramat Gan and at Hadassah Medical Center in Jerusalem.
“I think everything will be ok, I’m even sure of it,” says Segev Harel, a 26-year-old undergraduate student from Kibbutz Sde Nehemia in northern Israel, introducing himself as the first Israeli due to receive a shot in a video released by Sheba Medical Center.
Segev Harel, set to receive the first shot of Israel’s vaccine candidate. (Sheba Medical Center)
Speaking in a video shot by a friend, he says he is healthy and feels confident about the test.
“A lot of people have been harmed by coronavirus, health-wise, psychologically and economically. And if the small contribution I can make is to participate in this trial and give hope that we’re on the way to end the plague, I’ll have played my part,” he says.
-Nathan Jeffay
Watch Docu Nation Season 2: Resilience
when you join the ToI Community
Support The Times of Israel's independent journalism and receive access to our documentary series, Docu Nation: Resilience, premiering December 12.
In this season of Docu Nation, you can stream eight outstanding Israeli documentaries with English subtitles and then join a live online discussion with the filmmakers. The selected films show how resilience, hope, and growth can emerge from crisis.
When you watch Docu Nation, you’re also supporting Israeli creators at a time when it’s increasingly difficult for them to share their work globally.
To learn more about Docu Nation: Resilience, click here.
Support ToI and get Docu Nation
Support ToI and get Docu Nation
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel eleven years ago - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this